Evidence map›Paper›PMID 36686264›Full record

ArticleAmerican journal of ophthalmology case reports2023

Acute macular neuroretinopathy secondary to central retinal artery occlusion.

Emérentienne Sarrasin, Ariane Malclès, David Sarraf

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Acute macular neuroretinopathy: is the name still appropriate?Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Emérentienne SarrasinDepartment of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland.
Ariane MalclèsDepartment of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland.
David SarrafStein Eye Institute, University of California Los Angeles, Los Angeles, CA, USA.
University Hospital of Geneva · CHUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Acute Macular Neuroretinopathy (AMN) may be the result of deep retinal capillary plexus (DCP) impairment, but its mechanism remains elusive. A recent study has described simultaneous onset of Paracentral Acute Middle Maculopathy (PAMM) and AMN, suggesting a related pathogenic pathway. In this report, we analyze and describe the imaging characteristics of patients with concomitant Central Retinal Artery Occlusion (CRAO) and AMN and suggest a mechanistic pathway to explain this relationship. Observations: A total of 2 cases of CRAO, arteritic and non arteritic, were included in this report. At initial presentation, outer retinal layers were intact. At the two-week follow-up visit, both cases displayed Henle fiber layer hyperreflectivity and ellipsoid zone disruption consistent with AMN. Conclusions: Secondary development of AMN in CRAO is a new finding. DCP ischemia secondary to CRAO may lead to Henle fiber layer disruption, leading to the characteristic findings of AMN.

Indexed as

AMNAMN, Acute Macular NeuroretinopathyAMN secondary to CRAOAPMPPE, Acute Posterior Multifocal Placoid Pigment EpitheliopathyASHHASHH, Angular Sign of HFL HyperreflectivityCRAOCRAO, Central Retinal Artery OcclusionCRVO, Central Retinal Vein OcclusionDCP, Deep Capillary PlexusEZ, Ellipsoid ZoneFA, Fluorescein AngiogramHFL, Henle Fiber LayerINL, Inner Nuclear LayerIZ, Interdigitation ZoneOCT, Optical Coherence TomographyOD, Oculus DexterONL, Outer Nuclear LayerOPL, Outer Plexiform LayerOS, Oculus SinisterPAMMPAMM, Paracentral Acute Middle MaculopathySD, Spectral Domain

Identifiers

PMID36686264
PMCPMC9849867
OpenAlexW4313574656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.